UroDummies

LDR Brachytherapy in Community Practice: Expanding Access Through Collaborative Care

A multidisciplinary panel examines how community-based LDR brachytherapy programs can expand access to prostate cancer treatment while reducing travel and treatment burden.

Cardiovascular Risk During Systemic Therapy for Prostate Cancer

Kristen Scarpato, MD, MPH, reviews cardiovascular and metabolic considerations for patients receiving systemic therapy for prostate cancer.

Why Low-Dose-Rate Brachytherapy Deserves a Second Look

Why low-dose-rate brachytherapy deserves renewed consideration for localized prostate cancer.

The ARACOG Study: Neurourologic Cognition

ARACOG examines cognitive change during advanced prostate cancer treatment.

PTEN Loss and AKT Inhibition in Metastatic Prostate Cancer

Understanding PTEN loss and capivasertib in prostate cancer

Can PSMA-PET Improve Outcomes in Prostate Cancer?

PSMA PET guides targeted salvage radiation planning.